The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins

Journal of Molecular Neuroscience

Volumn 57, Issue 2, 2015, Pages 231-242

  Simchon Tenenbaum, Yaarit ^a   Weizman, Abraham ^c   Rehavi, Moshe ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Adelson Center for the Biology of Addictive Diseases   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Brain derived neurotrophic factor (BDNF); Cocaine; Doublecortin (DCX); Methylphenidate (MPH)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; DOUBLECORTIN; MESSENGER RNA; METHYLPHENIDATE; SYNAPTOPHYSIN; TAU PROTEIN; CENTRAL STIMULANT AGENT; DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE;

AGE; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; LATENT PERIOD; MALE; MORRIS WATER MAZE TEST; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TIME TO TREATMENT; VELOCITY; ANIMAL; BRAIN; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; MALE; METHYLPHENIDATE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOPHYSIN; TAU PROTEINS;

EID: 84942197880     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-015-0611-9     Document Type: Article

References (66)

1. Algahim MF, Yang PB, Burau KD, Swann AC, Dafny N (2010) Repetitive ritalin treatment modulates the diurnal activity pattern of young SD male rats. Cent Nerv Syst Agents Med Chem 10:247–257
2. Andersen SL, Sonntag KC (2014) Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood. Front Synaptic Neurosci 6:1
3. Askenasy EP, Taber KH, Yang PB, Dafny N (2007) Methylphenidate (Ritalin): behavioral studies in the rat. Int J Neurosci 117:757–794
4. Avila J, de Barreda EG, Fuster-Matanzo A, Simon D, Llorens-Martin M, Engel T, Lucas JJ, Diaz-Hernandez M, Hernandez F (2012) Looking for novel functions of tau. Biochem Soc Trans 40:653–655
5. Banerjee PS, Aston J, Khundakar AA, Zetterstrom TS (2009) Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur J Neurosci 29:465–476
6. Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc 1:1306–1311
7. Bruchmuller K, Margraf J, Schneider S (2012) Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. J Consult Clin Psychol 80:128–138
8. Carmack SA, Block CL, Howell KK, Anagnostaras SG (2014) Methylphenidate enhances acquisition and retention of spatial memory. Neurosci Lett 567:45–50
9. Carrey N, McFadyen MP, Brown RE (2000) Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. J Child Adolesc Psychopharmacol 10:277–286
10. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL (1996) Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607–616
11. Chase T, Carrey N, Soo E, Wilkinson M (2007) Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 144:969–984
12. Chilakamarri JK, Filkowski MM, Ghaemi SN (2011) Misdiagnosis of bipolar disorder in children and adolescents: a comparison with ADHD and major depressive disorder. Ann Clin Psychiatry 23:25–29
13. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15(532–534):536–537
14. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
15. Damianopoulos EN, Carey RJ (1992) Conditioning, habituation and behavioral reorganization factors in chronic cocaine effects. Behav Brain Res 49:149–157
16. Deacon RM (2006) Housing, husbandry and handling of rodents for behavioral experiments. Nat Protoc 1:936–946
17. Del Olmo N, Higuera-Matas A, Miguens M, Garcia-Lecumberri C, Borcel E, Solis JM, Ambrosio E (2006) Hippocampal synaptic plasticity and water maze learning in cocaine self-administered rats. Ann N Y Acad Sci 1074:427–437
18. Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3:1141–1154
19. Eshkind LG, Leube RE (1995) Mice lacking synaptophysin reproduce and form typical synaptic vesicles. Cell Tissue Res 282:423–433
20. Findling RL (2008) Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clin Ther 30:942–957
21. Fone KC, Nutt DJ (2005) Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol 5:87–93
22. Friedman A, Frankel M, Flaumenhaft Y, Merenlender A, Pinhasov A, Feder Y, Taler M, Gil-Ad I, Abeles M, Yadid G (2009) Programmed acute electrical stimulation of ventral tegmental area alleviates depressive-like behavior. Neuropsychopharmacology 34:1057–1066
23. Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA (2010) Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res 62:523–529
24. Fumagalli F, Di Pasquale L, Caffino L, Racagni G, Riva MA (2007) Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 26:2756–2763
25. Giannotti G, Caffino L, Calabrese F, Racagni G, Riva MA, Fumagalli F (2014) Prolonged abstinence from developmental cocaine exposure dysregulates BDNF and its signaling network in the medial prefrontal cortex of adult rats. Int J Neuropsychopharmacol 17:625–634
26. Gleeson JG, Lin PT, Flanagan LA, Walsh CA (1999) Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 23:257–271
27. Gomes KM, Souza RP, Valvassori SS, Reus GZ, Inacio CG, Martins MR, Comim CM, Quevedo J (2009) Chronic methylphenidate-effects over circadian cycle of young and adult rats submitted to open-field and object recognition tests. Curr Neurovasc Res 6:259–266
28. Guo T, Yang C, Guo L, Liu K (2012) A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD. Neurosci Lett 528:11–15
29. Heyser CJ, McNaughton CH, Vishnevetsky D, Fienberg AA (2013) Methylphenidate restores novel object recognition in DARPP-32 knockout mice. Behav Brain Res 253:266–273
30. Heyser CJ, Pelletier M, Ferris JS (2004) The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Ann N Y Acad Sci 1021:465–469
31. Howell LL, Negus SS (2014) Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol 69:129–176
32. Huttner WB, Schmidt A (2000) Lipids, lipid modification and lipid-protein interaction in membrane budding and fission—insights from the roles of endophilin A1 and synaptophysin in synaptic vesicle endocytosis. Curr Opin Neurobiol 10:543–551
33. Jones Z, Dafny N (2013) Dose response effect of methylphenidate on ventral tegmental area neurons and animal behavior. Brain Res Bull 96:86–92
34. Jones Z, Dafny N (2014) Acute and chronic dose-response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior. J Neural Transm 121:327–345
35. Kawauchi T, Hoshino M (2008) Molecular pathways regulating cytoskeletal organization and morphological changes in migrating neurons. Dev Neurosci 30:36–46
36. Kishi T, Matsuda Y, Iwata N, Correll CU (2013) Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 74:e1169–e1180
37. Kuczenski R, Segal DS (2005) Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57:1391–1396
38. Li X, DeJoseph MR, Urban JH, Bahi A, Dreyer JL, Meredith GE, Ford KA, Ferrario CR, Loweth JA, Wolf ME (2013) Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci 33:1130–1142
39. Linssen AM, Sambeth A, Vuurman EF, Riedel WJ (2014) Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies. Int J Neuropsychopharmacol 17:961–977
40. Lu B, Martinowich K (2008) Cell biology of BDNF and its relevance to schizophrenia. Novartis Found Symp 289:119–129 discussion 129–135, 193–115
41. Maher B (2008) Poll results: look who’s doping. Nature 452:674–675
42. Maier, L.J., Liechti, M.E., Herzig, F. & Schaub, M.P. (2013) To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One, 8, e77967.
43. Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73–83
44. McMahon HT, Bolshakov VY, Janz R, Hammer RE, Siegelbaum SA, Sudhof TC (1996) Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc Natl Acad Sci U S A 93:4760–4764
45. Morley CP (2010) Disparities in ADHD assessment, diagnosis, and treatment. Int J Psychiatry Med 40:383–389
46. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547
47. Normann C, Berger M (2008) Neuroenhancement: status quo and perspectives. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):110–114
48. Pierce RC, Pierce-Bancroft AF, Prasad BM (1999) Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade. J Neurosci 19:8685–8695
49. Quintero GC (2013) Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatr Dis Treat 9:1499–1512
50. Scherer EB, da Cunha MJ, Matte C, Schmitz F, Netto CA, Wyse AT (2010) Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobiol Learn Mem 94:247–253
51. Schmidt HD, McGinty JF, West AE, Sadri-Vakili G (2013) Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med 3:a012047
52. Schwartz K, Nachman R, Yossifoff M, Sapir R, Weizman A, Rehavi M (2007) Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2. J Neural Transm 114:427–430
53. Simchon Y, Weizman A, Rehavi M (2010) The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD. Eur Neuropsychopharmacol 20:714–720
54. Spalletta G, Pasini A, Pau F, Guido G, Menghini L, Caltagirone C (2001) Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities. J Neural Transm 108:1203–1216
55. Tang A, Wanchoo SJ, Swann AC, Dafny N (2009) Psychostimulant treatment for ADHD is modulated by prefrontal cortex manipulation. Brain Res Bull 80:353–358
56. Teter CJ, Falone AE, Cranford JA, Boyd CJ, McCabe SE (2010) Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J Subst Abus Treat 38:292–298
57. Thiel G (1993) Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles. Brain Pathol 3:87–95
58. Thiele C, Hannah MJ, Fahrenholz F, Huttner WB (2000) Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2:42–49
59. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, et al (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456–463
60. Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:557–569
61. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848–858
62. Warren BL, Iniguez SD, Alcantara LF, Wright KN, Parise EM, Weakley SK, Bolanos-Guzman CA (2011) Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci 31:10347–10358
63. Willcutt EG (2012) The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9:490–499
64. Yang PB, Swann AC, Dafny N (2006) Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull 71:301–310
65. Yano M, Steiner H (2007) Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 28:588–596
66. Zubrycki EM, Giordano M, Sanberg PR (1990) The effects of cocaine on multivariate locomotor behavior and defecation. Behav Brain Res 36:155–159